Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cancer Abstracts

Lad T, Wagner H, Piantadosi S. Randomized Phase II evaluation of preoperative chemotherapy alone and radiotherapy alone in stage Ilia non-small cell lung cancer. (Abstract) Proc Amer Soc Clin Oncol 1991 10 258. [Pg.192]

Turrisi A, Glover DJ, Mason B, et al. Long term results of platinum etoposide (PE) + twice daily thoracic radiotherapy (TRT) for limited small-cell lung cancer (abstract 975). Proc Am Soc Clin Oncol 1995 14 363. [Pg.211]

Glisson BS, Lee JS, Shin DM, et al. Topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic radiation in patients with limited small-cell lung cancer (abstract 1929). 2000 19 493a. [Pg.213]

Siani A, Cunningham D, Norman AR et al. Multicentre randomized trial of protracted venous infusion (PVI) 5 FU compared to 5 FU/folinic acid (5FU/FA) as adjuvant therapy for colorectal cancer [Abstract]. Proc Am Soc Clin Oncol 2000 19 240a. [Pg.288]

Anne PR, Edmonston TB, Rose D, et al. Microsatellite instability predicts for tumor response in a prospective trial of preoperative 5-FU, CPT-11, and radiation for locally advanced rectal cancer [Abstract]. Int J Radiat Oncol Biol Phys 2000 48(3 Suppl) 121. [Pg.289]

Thompson, L.U., Li, T., Chen, J., and Goss, P.E. 2000. Biological effects of dietary flaxseed in patients with breast cancer (abstract). Breast Cancer Res. Treat. 64, p. 50. [Pg.94]

Zhang RF, Chen CS, Yu L, Sun HL, Fu CG, Xu HD Aspergillus versicolor and sterigmatocystin might be related to genesis of gastric cancer. Abstract 7th Int Union of Pure and Applied Chemistry (lUPAC), International Symposium on Mycotoxins and Phytotoxins, Tokyo 1988. Dutton MF Fumonisins, mycotoxins of increasing importance Their nature and their effects. Pharmacol Ther 1996 70 137-161. [Pg.202]

Harris L, Winer E, Batist G, Rovira D, Navari R, Lee L the TLC D-99 Study Group. Phase III study of TLC D-99 (liposome encapsulated doxorubicin) vs. free doxorubicin in patients with metastatic breast cancer (Abstract 26). Proc Am Soc Clin Oncol 1998 17 A474. [Pg.259]

Niell HB, Herndon JE, Miller AA, et al. Randomized phase III Integroup trial (CALGB 9732) of etoposide (VP-16) and cisplatin (DDP) with or widiout paclitaxel (TAX) in patients widi extensive stage small cell lung cancer [abstract]. Proc ASCO 2002 21 293a. [Pg.2381]

Kakar. S., and Wilson. C. W. M. Ascorbic acid metabolism in human cancer. Abstract. Proc. Nutr. Soc. 33 110,1974. [Pg.608]

Breast. Igaku-Shoin, New York, pp 1-8 Kolb TM, Lichy J, Newhouse JH (1998) Occult cancer in women with dense breast detection with screening US, diagnostic yield and tumor characteristics. Radiology 207 191-199 Kolb TM, Lichy J, Newhouse JH (2000) The impact of bilateral whole breast ultrasound in women with dense breasts and recently diagnosed breast cancer (abstract). Radiology 217 (P) 318... [Pg.109]

Ross PJ, Meenan J, O Doherty M, Calara J, Palmer DH, Heatley S, Chow PH et al (2008) Novel delivery via endoscopic ultrasound of a P brachytherapy device in addition to gemcitabine in advanced pancreatic cancer. Abstract No. 205. ASCO Gastrointestinal Cancers Symposium... [Pg.686]

Tiwari, R., Toppino, A., Byun, Y. et al. 2009a. Cage-iodination of o-carboranyl nucleoside analogs for the diagnosis and treatment of cancer. Abstracts of Papers, 237th ACS National Meeting, Salt Lake City, UT, United States, March 22-26, 2009. [Pg.143]

Treatment of Patients with Advanced Solid Cancers. Abstract No. 1009, 37th American Society of Clinical Oncologists Meeting, San Francisco, May 12-15, 2001. [Pg.163]

CAS = Chemical Abstracts Services DOT/UN/NA/IMCO = Department of Transportation/United Nations/North America/International Maritime Dangerous Goods Code EPA = Environmental Protection Agency HSDB = Hazardous Substance Data Bank NCI = National Cancer Institute NIOSH = National Institute for Occupational Safety and Health OHM/TADS = Oil and Hazardous Materials/Technical Assistance Data System RTECS = Registry of Toxic Effects of Chemical Substances... [Pg.204]

Archer, V.J., Oncology Overview, Selected Abstracts on Risk of Cancer from Exposure to Low Level Ionizing Radiation, PB84-922906, International Cancer Research Data Bank Program, National Cancer Institute, U.S. Department of Health and Human Services, Salt Lake City, Utah, (August 1984) ... [Pg.499]

Cauley JA, Martino S, Barrett-Connor E et al. (2004) Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by Gail risk assessment results of the Continuing Outcomes Relevant to Evista (CORE) trial. Abstract 1018. American Society of Clinical Oncology... [Pg.275]

Martino S, Disch D, Dowsett S, Mershon J (2005b) Raloxifene and Breast Cancer Risk Reduction based on Breast Cancer Family History. Abstract. ASCO, San Francisco... [Pg.278]

Purdie D, Cauley J, Disch D et al. (2004) Effect of raloxifene on incidence of invasive breast cancer in postmenopausal women having a history of prior hormone therapy use results of the CORE trial Abstract. European Society of Medical Oncology (ESMO), Vienna... [Pg.278]

Jordan VC, Glusman JE, Eckert S, Lippman M, Powles T, Costa A, et al. (1998) Incident primary breast cancer are reduced by raloxifen integrated data from multicenter, double-blind, randomized trial in 12,000 postmenopausal women. Proc Am Soc Clin Oncol 17 122a (abstract)... [Pg.297]

Altmannsberger M, Dirk T, Droese M, Weber K, Osborn M (1986) Keratin polypeptide distribu tion in benign and malignant breast tumors subdivision of ductal carcinomas using monoclo nal antibodies. Virchows Arch B Cell Pathol Incl Mol Pathol 51(3) 265 275 Assefnia S, Jones LP, Torre KM, Furth PA (2006) Expression of p63 in a mouse model of Brcal mutation related breast cancer. Poster presented at the Annual Meeting of the American Association for Cancer Research, Washington, DC (Meeting Abstracts)... [Pg.125]

Abstract The supramolecular composites containing fullerenes C60 immobilized at nanosilica were used for the design of the molecular systems that can be an effective agent in cancer photodynamic therapy (PDT). In particular, it was shown that photoexcited fullerene C60-containing composites decrease viability of transformed cells, intensify the process of lipid peroxidation (LPO) in cell membranes and accumulation of low-molecular weight DNA fragments, and also decrease the activity of electron-transport chain of mitochondria. [Pg.123]


See other pages where Cancer Abstracts is mentioned: [Pg.109]    [Pg.114]    [Pg.166]    [Pg.109]    [Pg.114]    [Pg.166]    [Pg.562]    [Pg.81]    [Pg.113]    [Pg.227]    [Pg.90]    [Pg.115]    [Pg.243]    [Pg.51]    [Pg.79]    [Pg.223]    [Pg.283]   
See also in sourсe #XX -- [ Pg.274 ]




SEARCH



Cancer Chemotherapy Abstracts

© 2024 chempedia.info